SciELO - Scientific Electronic Library Online

 
vol.35 issue3Arterial hypertension and dyslipidemiaSport: physiological modifications and evaluation for the prevention of sudden death (Part II). Athlete`s heart author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Related links

Share


Revista Uruguaya de Cardiología

Print version ISSN 0797-0048On-line version ISSN 1688-0420

Abstract

ACHE, Yamel; GUAMAN, Carlos  and  RAMOS, María Victoria. Lo mejor del Congreso 2020 de la Sociedad Europea de Cardiología: la experiencia digital. Rev.Urug.Cardiol. [online]. 2020, vol.35, n.3, pp.133-172.  Epub Dec 01, 2020. ISSN 0797-0048.  https://doi.org/10.29277/cardio.35.3.11.

La necesidad de distanciamiento social impuesta por la actual pandemia por coronavirus obligó a las diferentes sociedades científicas a realizar sus actividades en formato completamente virtual. La Sociedad Europea de Cardiología no ha sido la excepción. Desde el 29 de agosto al 1 de septiembre de 2020 se celebró este evento sin precedentes que, además de contar con 125.000 profesionales de 213 países, permitió el acceso gratuito a todos los cibernautas. De esta manera, la actualidad en cardiología pudo llegar a todos los rincones del mundo, pese a las circunstancias tan complejas. Como ya es tradición de la revista, realizamos un resumen de los principales ensayos presentados durante el congreso:

- Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4)

- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (The EMPEROR-Reduced Trial Investigators)

- Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM)

- Angiotensin Receptor Neprilysin Inhibition Compared with Individualized Medical Therapy for Comorbidities in Patients with Heart Failure and Preserved Ejection Fraction (The PARALLAX Trial)

- A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease (DAPA-CKD)

- Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation (POPULAR TAVI (Cohort A))

- Colchicine in Patients with Chronic Coronary Disease (The LoDoCo2 Trial Investigators)

- Pharmacological Blood Pressure-Lowering for Primary and Secondary Prevention of Cardiovascular Disease Across Different Levels of Blood Pressure (BPLTTC)

- Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (The BRACE CORONA Trial)

- Randomized Trial of Transfusion Strategies in Patients with Myocardial Infarction and Anemia (REALITY Trial)

Keywords : EAST-AFNET 4; EMPEROR; EXPLORER-HCM; PARALLAX; DAPA-CKD; POPULAR-TAVI; LODOCO2; BPLTTC; BRACE CORONA; REALITY.

        · abstract in English | Portuguese     · text in Spanish     · Spanish ( pdf )